An expert perspective on the evolving role of neoadjuvant therapy and how sequencing methods for the treatment of early-stage breast cancer have been affected during the COVID-19 pandemic.
GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer
Patients with breast cancer experience significant weight loss after using GLP-1 receptor agonists, highlighting potential benefits for obesity management in this population.